None
Conditions
Interventions
Sacral canal group (R group):Hydromorphone 1mg (diluted to 20ml with normal saline)
Control group (Group C):20ml with normal saline
Sponsors
Dongguan Tungwah hospital
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients selected to undergo thoracoscopic lobectomy under elective general anesthesia were of all genders, aged 20-65 years, BMI 18-25 kg/m2, ASA grade I or II.
Exclusion criteria
Exclusion criteria: A history of allergy to ropivacaine, long-term use of opioids, sedatives, antidepressants, and monoamine oxidase inhibitors, a history of peptic ulcer, hypertension, coronary heart disease, central nervous system disease, or mental illness, and a history of refusal to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-40 score;C-reactive protein, IL-6, IL-8, TNF-a, and cortisol levels; | — |
Secondary
| Measure | Time frame |
|---|---|
| Consumption of opioids;The number of analgesic pump compressions and the number of effective compressions;Rest and cough pain score (VAS);The Prince-Henry pain score;Mean arterial blood pressure and heart rate; | — |
Countries
China
Contacts
Public ContactXueping Li
Dongguan Tungwah hospital
Outcome results
None listed